Pharma News
-
ASLAN signs news commercialisation agreement with BioGenetics
Pharma | News | 0 Comment | 11 Mar, 2019
ASLAN Pharmaceuticals, a clinical-stage oncology-focused biopharmaceutical company developing novel therapeutics for global markets, and BioGenetics Co Ltd, a leading South Korean healthcar...Read more
-
TaiwanJ Pharma signs $26M deal with Newsoara Biopharma
Pharma | News | 0 Comment | 11 Mar, 2019
TaiwanJ Pharmaceuticals has signed a $26 million contract with Newsoara Biopharma to license out its drug candidate JKB-122 for further development in Asia. On March 2nd, 2019, TaiwanJ ann...Read more
-
West opens new digital technology centre in India
Pharma | News | 0 Comment | 08 Mar, 2019
West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, has officially opened the Company’s new Digital Technology centre (DTC)...Read more
-
Pharma | News | 0 Comment | 07 Mar, 2019
Pacira Pharmaceuticals, Inc. and MyoScience, Inc. a privately held medical technology company, have announced the signing of a definitive agreement for the acquisition of MyoScience by...Read more
-
Eisai submits marketing authorization application for Insomnia drug
Pharma | News | 0 Comment | 07 Mar, 2019
Eisai Co., Ltd. has announced that a marketing authorization application has been submitted in Japan for lemborexant, an investigational agent for sleep-wake regulation, seeking approval fo...Read more
-
Glenmark appoints Alessandro Riva as CEO of its New Innovation Company
Pharma | News | 0 Comment | 06 Mar, 2019
Glenmark Pharmaceuticals has announced that Alessandro Riva, MD, will join its new innovation company as Chief Executive Officer. Alessandro is currently Executive Vice President, Oncology ...Read more
-
Sagent Pharma acquires Raleigh manufacturing site
Pharma | News | 0 Comment | 05 Mar, 2019
Nichi-Iko Pharmaceutical and Sagent Pharmaceuticals, a Nichi-Iko Group Company, a leader of specialty pharmaceutical products with an emphasis on the injectable market, has announced that S...Read more
-
AGC completes acquisition of Malgrat Pharma Chemicals
Pharma | News | 0 Comment | 04 Mar, 2019
Tokyo based AGC Inc. has announced on March 4 the completion of its acquisition of Spain's synthetic pharmaceutical active ingredient manufacturer, Malgrat Pharma Chemic...Read more
-
Ascletis brings Former MSD Global VP on board
Pharma | News | 0 Comment | 01 Mar, 2019
Ascletis Pharma Inc., an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver d...Read more
-
Sanofi appoints New General Manager China
Pharma | News | 0 Comment | 01 Mar, 2019
Sanofi has announced that Pius S. Hornstein, PhD, has been appointed the new General Manager China, China & Emerging Markets Global Business Unit (GBU) of Sanofi and...Read more
-
Pharma in South East Asia booming as CPhI to open event in Thailand
Pharma | News | 0 Comment | 01 Mar, 2019
CPhI South East Asia’s (March 12-14, 2019) first visit to the fast-growing pharma economy of Thailand could not come at a better moment. The Country is experiencing aboom amongst phar...Read more
-
Bausch Health to acquire assets of Synergy Pharma
Pharma | News | 0 Comment | 27 Feb, 2019
Bausch Health Companies Inc. has announced that the Company was selected as the successful bidder to acquire certain assets of Synergy Pharmaceuticals Inc. for a cash purchase price of appr...Read more
-
CStone Pharma announces its listing on Hong Kong Stock Exchange
Pharma | News | 0 Comment | 27 Feb, 2019
CStone Pharmaceuticals announced the listing of 186,396,000 shares on the Main Board of the Hong Kong Stock Exchange. Based on the offer price of HK$12.00 per share, the net proce...Read more
-
HOOKIPA Pharma raises $37.4M in Series D Financing
Pharma | News | 0 Comment | 26 Feb, 2019
HOOKIPA Pharma, a clinical stage biopharmaceutical company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platfor...Read more
-
Novartis to license Akcea-Ionis cardiac disease drug
Pharma | News | 0 Comment | 26 Feb, 2019
Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals announced that Novartis has exercised its option to license AKCEA-APO(a)-LRx, a drug to treat patients with elevated levels of...Read more
-
Glenmark announces results from new analysis on Ryaltris™
Pharma | News | 0 Comment | 26 Feb, 2019
Ryaltris (olopatadine hydrochloride [665 mcg] and mometasone furoate [25 mcg]), formerly GSP 301 Nasal Spray, is the company’s leading respiratory pipeline asset and currently under r...Read more
-
GE to sell Biopharma business for $21.4B to Danaher
Pharma | News | 0 Comment | 26 Feb, 2019
GE has announced a definitive agreement to sell its BioPharma business to Danaher Corporation for a total consideration of $21.4 billion, including $21 billion in cash as well as Danaher&rs...Read more
-
EC approves Pfizer's ZIRABEV, a biosimilar to Avastin
Pharma | News | 0 Comment | 25 Feb, 2019
Pfizer recently announced that the European Commission (EC) has approved ZIRABEV for the treatment of metastatic carcinoma of the colon or rectum, metastatic breast cancer, unresectabl...Read more
